Valuation : Cegedim

Market Cap 141M 163M 132M 121M 227M 15.59B 228M 1.57B 612M 7.89B 614M 600M 26.15B P/E 2026 *
6.74x
P/E 2027 * 5.14x
Enterprise Value 303M 351M 284M 260M 488M 33.51B 490M 3.37B 1.32B 16.95B 1.32B 1.29B 56.19B EV / Sales 2026 *
0.46x
EV / Sales 2027 * 0.4x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 week-1.15%
Current month-0.39%
1 month+0.98%
3 months-11.76%
6 months-3.93%
Current year-24.41%
1 week 10.16
Extreme 10.16
10.4
1 month 10.1
Extreme 10.1
10.62
3 years 8.66
Extreme 8.66
20.7
5 years 8.66
Extreme 8.66
29.3
Manager TitleAgeSince
Chief Executive Officer 83 24/10/2009
Director of Finance/CFO - 13/06/2016
Corporate Officer/Principal 55 25/11/2015
Director TitleAgeSince
Chairman 83 24/10/2009
Director/Board Member 72 08/08/2010
Director/Board Member 55 25/10/2009
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-0.58%-4.37%-50.10% 164M
-0.72%+2.99%-37.23%+29.11% 435B
+0.76%+1.70%-19.05%+49.63% 256B
+4.54%+12.63%-22.08%+27.32% 150B
-7.34%+6.76%-62.43%+269.69% 48.92B
+1.23%+4.02%-28.46%+16.18% 48.25B
-0.30%-1.63%-23.42%+33.36% 24.91B
-0.06%-4.07%-21.80%+67.46% 20.32B
+2.37%+8.81%-5.88%+155.65% 17.14B
-0.86%+1.26%-25.79%+14.55% 14.23B
Average -0.04%+5.54%-25.05%+61.29% 112.68B
Weighted average by Cap. +0.28%+4.91%-29.86%+47.81%

Financials

2026 *2027 *
Net sales 660M 764M 618M 564M 1.06B 72.87B 1.07B 7.33B 2.86B 36.85B 2.87B 2.81B 122B 684M 792M 641M 585M 1.1B 75.57B 1.11B 7.6B 2.97B 38.22B 2.97B 2.91B 127B
Net income 21.3M 24.67M 19.97M 18.23M 34.3M 2.35B 34.44M 237M 92.42M 1.19B 92.61M 90.6M 3.95B 28M 32.43M 26.25M 23.96M 45.08M 3.09B 45.28M 311M 121M 1.56B 122M 119M 5.19B
Net Debt 162M 188M 152M 139M 261M 17.91B 262M 1.8B 704M 9.06B 705M 690M 30.04B 134M 155M 125M 114M 215M 14.78B 216M 1.49B 580M 7.47B 582M 569M 24.78B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
-
Date Price Change
28/08/26 €10.28 -0.39%
27/08/26 €10.32 -0.19%
26/08/26 €10.34 +0.98%
25/08/26 €10.24 +0.79%
24/08/26 €10.16 -2.31%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.28EUR
Average target price
15.50EUR
Spread / Average Target
+50.78%

Quarterly revenue - Rate of surprise